Concepedia

Publication | Open Access

Randomized phase III ANGEL study of rivoceranib (apatinib) + best supportive care (BSC) vs placebo + BSC in patients with advanced/metastatic gastric cancer who failed ≥2 prior chemotherapy regimens

DOIFull Paper Access

71

Citations

0

References

2019

Year

Yoon‐Koo Kang, W. Kang, Maria Di Bartolomeo, Ian Chau, Harry H. Yoon, Stefano Cascinu, Min‐Hee Ryu, J.G. Kim, K.-W. Lee, Sang Cheul Oh,
Annals of Oncology

No additional data available for this publication yet. Check back later!